ROCKET PHARMACEUTICALS, INC. (RCKT) Total liabilities 2016–2025
ROCKET PHARMACEUTICALS, INC. (RCKT) total liabilities at each fiscal year-end, per SEC filings.
$53.2MFY2025 · since FY2016: $56.5M → $53.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $53.2M | -17.4% |
| FY2024 | $64.5M | -12.6% |
| FY2023 | $73.8M | +18.7% |
| FY2022 | $62.1M | +46.9% |
| FY2021 | $42.3M | -51.6% |
| FY2020 | $87.3M | +34.7% |
| FY2019 | $64.8M | +13.2% |
| FY2018 | $57.3M | +1137.6% |
| FY2017 | $4.6M | -91.8% |
| FY2016 | $56.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice